Optimizing Arginine Deprivation for Hard-To-Treat Cancers

Oncotarget - United States
doi 10.18632/oncotarget.22099
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

High-Throughput Genomics and Clinical Outcome in Hard-To-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

Cancer Discovery
Oncology
2017English

Arginine Deprivation as a Targeted Therapy for Cancer

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2008English

Encapsulated Irinotecan Provides Novel Option for Hard-To-Treat Pancreatic Cancer

Journal of Community and Supportive Oncology
OncologyHematology
2016English

Arginine-Deprivation–induced Oxidative Damage sterilizesMycobacterium Tuberculosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

How We Treat Germ Cell Cancers

Cancer
Cancer ResearchOncology
2017English

Optimizing Pred(25) Is NP-Hard

Studies in Systems, Decision and Control
ControlSystems EngineeringFinanceAutomotive EngineeringDecision SciencesEconomicsEconometricsOptimizationComputer ScienceSocial Sciences
2017English

How I Treat Cancers of Unknown Primary

ESMO Open
Cancer ResearchOncology
2019English

Influence of Arginine Metabolites on Human Tumar Cell Viability Upon Arginine Deprivation in Vitro

Studia Biologica
2011English

Hard Decoding Algorithm for Optimizing Thresholds Under General Markovian Noise

Physical Review A
OpticsAtomicMolecular Physics,
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy